Overview

Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy with chemotherapy is more effective than radiation therapy alone in treating high-risk endometrial cancer. PURPOSE: This randomized phase III trial is studying radiation therapy and chemotherapy to see how well they work compared to radiation therapy alone in treating patients with high-risk endometrial cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Nordic Society for Gynaecologic Oncology
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Collaborator:
European Organisation for Research and Treatment of Cancer - EORTC
Treatments:
Doxorubicin
Epirubicin
Liposomal doxorubicin